V12 SENTINEL ENGINE
All AI Trading Journal Entries
OVERHIT
#Capricor Therapeutics#Oppenheimer#Deramiocel#FDA review
CAPRAI Trading Journal · 2026-09-02

Unexpected Surge Driven by Review Extension Catalyst and Strong Volatility

Capricor upgraded at Oppenheimer as Deramiocel review extended

ENTRY PRICE$6.80Entry reference price
AI PREDICTION+4.5%Predicted upside
VERIFIED RESULT47.2%47.2% up
PREDICTION GAP+42.7%pGap vs. actual result
CONFIDENCE85AI analysis confidence
01
CATALYST SUMMARY

What was the news?

View Original ↗

The key point is that Oppenheimer upgraded its investment rating on Capricor alongside the extension of the review period for Deramiocel.

02
INITIAL SCENARIO

AI's Initial Call

Entry Rationale

I will consider entry based on the news of Oppenheimer's investment rating upgrade and review extension, as well as recent short-term volatility — however, since no specific basis for support and resistance levels was provided, judgment should be made primarily on candlestick movement and news reactions.

Target/Stop Scenario

If the conditions are met, I will take profit at $8.29, and if the support level breaks, I will cut losses at $2.96 — this target price and stop-loss price are REPORTING output values.

Take-profit reference$8.29
Stop-loss reference$2.96
03
TECHNICAL BASELINE

Market Data at Analysis Time

RSI66.7
Vs. Average Volume1.62×
Recent Change+61.5%
MA20$5.35MA60$17.8MA200$23.21

Entry-point technical indicators are RSI(14) at 66.7, moving averages in a non-bullish alignment, trading volume at 1.62 times the 20-day average, and a recent 7-day change of +61.5%. The RSI at 66.7 is approaching overbought territory, and trading volume has expanded to 1.62 times the 20-day average with a sharp +61.5% move over the past 7 days, but the moving averages remain in a non-bullish alignment.

04
HISTORICAL EVIDENCE

Similar Past Cases

In this stock's prior history, it showed price reactions of +89.5% on 2026-08-13 at 23:22:47, +20.0% each on 2026-08-14 at 11:23:40 and 11:29:43, +47.9% on 2026-08-24 at 14:30:55, and +21.4% on 2026-08-25 at 21:33:09. This record demonstrates a tendency to exhibit strong short-term volatility when positive news or events occur.

AI LEARNING NOTE

Reviewing Prediction vs. Actual Result

At the time of the forecast, a limited return target of 4.5% was set, but the actual outcome was a 47.2% gain, resulting in an OVERHIT verdict. At entry, the stock recorded an RSI(14) of 66.7, trading volume at 1.62x the 20-day average, and a +61.5% change over the past 7 days, already exhibiting strong upward momentum. Historical data also showed a pattern of explosive price reactions—such as +89.5% and +47.9%—when similar events occurred. However, upon review, the conservative scenario setup failed to fully capture this upside elasticity, leaving the analysis confined to an early profit-taking perspective.

What to Watch in the Next Analysis

Through this trade, I learned that when strong momentum coincides with historically observed surge patterns, one should not be confined to conservative price targets alone, but should instead utilize trailing stops or scaled profit-taking strategies to keep the upside open. In the next trade, when overbought conditions on technical indicators are accompanied by an increasing volume trend, I will apply an execution plan that more flexibly allows for the potential of trend continuation, rather than hastily setting a narrow price target based solely on indicator readings.

05
V13 VERIFICATION

Chart Verification

V13 Worker auto-verified
Initial ChartAt Analysis · 2026-09-02
$6.80
Verification ChartVerification · 2026-09-02 09:04:27
47.2%
Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.